Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakesh Heer

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Cancer Research|October 3, 2008
The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancerEmma L Clark, Anne Coulson, Caroline Dalgliesh, et al.
Cancers|August 12, 2022
Detection of Microsatellite Instability in Colonoscopic Biopsies and Postal Urine Samples from Lynch Syndrome Cancer Patients Using a Multiplex PCR AssayRachel Phelps, Richard Gallon, Christine Hayes, et al.
British Journal of Cancer|January 31, 2018
Human ex vivo prostate tissue model system identifies ING3 as an oncoproteinUrszula L McClurg, Arash Nabbi, Charles Ricordel, et al.
BMJ Open|December 21, 2019
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocolEmma Clark, Miranda Morton, Shriya Sharma, et al.
Molecular Oncology|September 22, 2014
The co-chaperone p23 promotes prostate cancer motility and metastasisLaia Querol Cano, Derek N Lavery, Soraya Sin, et al.
Nature Reviews. Clinical Oncology|April 23, 2014
Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.
Nature Reviews. Clinical Oncology|September 13, 2017
Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.
Stem Cells Translational Medicine|March 15, 2020
Propagation of human prostate tissue from induced pluripotent stem cellsAnastasia C Hepburn, Emma L Curry, Mohammad Moad, et al.
European Urology|April 16, 2013
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cellsMohammad Moad, Deepali Pal, Anastasia C Hepburn, et al.
Cell Reports|August 17, 2017
Multipotent Basal Stem Cells, Maintained in Localized Proximal Niches, Support Directed Long-Ranging Epithelial Flows in Human ProstatesMohammad Moad, Edouard Hannezo, Simon J Buczacki, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Cancer Research|October 3, 2008
The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancerEmma L Clark, Anne Coulson, Caroline Dalgliesh, et al.
Cancers|August 12, 2022
Detection of Microsatellite Instability in Colonoscopic Biopsies and Postal Urine Samples from Lynch Syndrome Cancer Patients Using a Multiplex PCR AssayRachel Phelps, Richard Gallon, Christine Hayes, et al.
British Journal of Cancer|January 31, 2018
Human ex vivo prostate tissue model system identifies ING3 as an oncoproteinUrszula L McClurg, Arash Nabbi, Charles Ricordel, et al.
BMJ Open|December 21, 2019
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocolEmma Clark, Miranda Morton, Shriya Sharma, et al.
Molecular Oncology|September 22, 2014
The co-chaperone p23 promotes prostate cancer motility and metastasisLaia Querol Cano, Derek N Lavery, Soraya Sin, et al.
Nature Reviews. Clinical Oncology|April 23, 2014
Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.
Nature Reviews. Clinical Oncology|September 13, 2017
Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.
Stem Cells Translational Medicine|March 15, 2020
Propagation of human prostate tissue from induced pluripotent stem cellsAnastasia C Hepburn, Emma L Curry, Mohammad Moad, et al.
European Urology|April 16, 2013
A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cellsMohammad Moad, Deepali Pal, Anastasia C Hepburn, et al.
Cell Reports|August 17, 2017
Multipotent Basal Stem Cells, Maintained in Localized Proximal Niches, Support Directed Long-Ranging Epithelial Flows in Human ProstatesMohammad Moad, Edouard Hannezo, Simon J Buczacki, et al.
Pageof 8